Gilotrif (afatinib) Tablets, for Oral Use
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
April 2016
WARNINGS AND PRECAUTIONS
Diarrhea
In Study 2, diarrhea occurred in 75% of patients treated with GILOTRIF...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts